Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Kelonia Therapeutics Launches with $50M Series A

2022-04-29
BOSTON, MA, Kelonia Therapeutics, a biotech company, launched with a $50 million Series A financing.
Kelonia Therapeutics, a biotech company working in vivo gene delivery, launched with a $50 million Series A financing to usher in a new era of genetic medicines for a wide range of diseases.

Kelonia is backed by a strong syndicate of investors with a track record of successfully launching and building disruptive biotech companies. Alta Partners, Horizons Ventures, Venrock and other investors participated in the Series A round.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors